Multiple amino acid substitutions involved in enhanced pathogenicity of LPAI H9N2 in mice

Infection, Genetics and Evolution

Volumn 11, Issue 7, 2011, Pages 1790-1797

  Zhang, Zongde ^a   Hu, Sishun ^a   Li, Zili ^a   Wang, Xiliang ^a   Liu, Mei ^a   Guo, Zisheng ^a   Li, Shaowen ^a   Xiao, Yuncai ^a   Bi, Dingren ^a   Jin, Hui ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Adaptation; Avian influenza virus; Cytokine; H9N2; MicroRNA

Indexed keywords

BETA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MICRORNA; MICRORNA 1904; MICRORNA 1940; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; INFLUENZA A; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H9N2; M1 GENE; MICROBIAL GROWTH; MOUSE; MUTATIONAL ANALYSIS; NEURAMINIDASE GENE; NONHUMAN; NONSTRUCTURAL 1 GENE; NUCLEOTIDE SEQUENCE; POLYMERASE ACIDIC GENE; POLYMERASE BASIC 2 GENE; PRIORITY JOURNAL; VIRAL TROPISM; VIRUS GENE; VIRUS TRANSMISSION; VIRUS VIRULENCE; WILD TYPE;

ADAPTATION, PHYSIOLOGICAL; AMINO ACID SUBSTITUTION; ANIMALS; BIRDS; CYTOKINES; GENES, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; MICRORNAS; ORTHOMYXOVIRIDAE INFECTIONS; VIRULENCE;

AVES; AVIAN INFLUENZA VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 80053564718     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2011.07.025     Document Type: Article

References (43)

1. Ahluwalia J.K., Khan S.Z., Soni K., Rawat P., Gupta A., Hariharan M., Scaria V., Lalwani M., Pillai B., Mitra D., Brahmachari S.K. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 2008, 5:117.
2. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
3. Brown E.G., Bailly J.E. Genetic analysis of mouse-adapted influenza A virus identifies roles for the NA, PB1, and PB2 genes in virulence. Virus Res. 1999, 61:63-76.
4. Butt K.M., Smith G.J., Chen H., Zhang L.J., Leung Y.H., Xu K.M., Lim W., Webster R.G., Yuen K.Y., Peiris J.S., Guan Y. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J. Clin. Microbiol. 2005, 43:5760-5767.
5. Cheung C.Y., Poon L.L., Lau A.S., Luk W., Lau Y.L., Shortridge K.F., Gordon S., Guan Y., Peiris J.S. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 2002, 360:1831-1837.
6. Choi Y.K., Ozaki H., Webby R.J., Webster R.G., Peiris J.S., Poon L., Butt C., Leung Y.H., Guan Y. Continuing evolution of H9N2 influenza viruses in Southeastern China. J. Virol. 2004, 78:8609-8614.
7. Conenello G.M., Zamarin D., Perrone L.A., Tumpey T., Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 2007, 3:1414-1421.
8. Cullen B.R. Viruses and microRNAs. Nat. Genet. 2006, 38(Suppl):S25-30.
9. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., Hoang D.M., Chau N.V., Khanh T.H., Dong V.C., Qui P.T., Cam B.V., Ha do Q., Guan Y., Peiris J.S., Chinh N.T., Hien T.T., Farrar J. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006, 12:1203-1207.
10. de Wit E., Munster V.J., van Riel D., Beyer W.E., Rimmelzwaan G.F., Kuiken T., Osterhaus A.D., Fouchier R.A. Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J. Virol. 2010, 84:1597-1606.
11. Dias A., Bouvier D., Crepin T., McCarthy A.A., Hart D.J., Baudin F., Cusack S., Ruigrok R.W. The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 2009, 458:914-918.
12. Gabriel G., Dauber B., Wolff T., Planz O., Klenk H.D., Stech J. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc. Natl Acad. Sci. USA 2005, 102:18590-18595.
13. Guan Y., Shortridge K.F., Krauss S., Webster R.G. Molecular characterization of H9N2 influenza viruses: were they the donors of the " internal" genes of H5N1 viruses in Hong Kong?. Proc. Natl Acad. Sci. USA 1999, 96:9363-9367.
14. Hatta M., Gao P., Halfmann P., Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001, 293:1840-1842.
15. Herfst S., Chutinimitkul S., Ye J., de Wit E., Munster V.J., Schrauwen E.J., Bestebroer T.M., Jonges M., Meijer A., Koopmans M., Rimmelzwaan G.F., Osterhaus A.D., Perez D.R., Fouchier R.A. Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J. Virol. 2010, 84:3752-3758.
16. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl Acad. Sci. USA 2000, 97:6108-6113.
17. Ilyushina N.A., Khalenkov A.M., Seiler J.P., Forrest H.L., Bovin N.V., Marjuki H., Barman S., Webster R.G., Webby R.J. Adaptation of pandemic H1N1 influenza viruses in mice. J. Virol. 2010, 84:8607-8616.
18. Jiao P., Tian G., Li Y., Deng G., Jiang Y., Liu C., Liu W., Bu Z., Kawaoka Y., Chen H. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J. Virol. 2008, 82:1146-1154.
19. Kashiwagi T., Hara K., Nakazono Y., Hamada N., Watanabe H. Artificial hybrids of influenza A virus RNA polymerase reveal PA subunit modulates its thermal sensitivity. PLoS One 2010, 5:e15140.
20. Kawaoka Y., Webster R.G. Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc. Natl Acad. Sci. USA 1988, 85:324-328.
21. Kobasa D., Kodihalli S., Luo M., Castrucci M.R., Donatelli I., Suzuki Y., Suzuki T., Kawaoka Y. Amino acid residues contributing to the substrate specificity of the influenza A virus neuraminidase. J. Virol. 1999, 73:6743-6751.
22. Lecellier C.H., Dunoyer P., Arar K., Lehmann-Che J., Eyquem S., Himber C., Saib A., Voinnet O. A cellular microRNA mediates antiviral defense in human cells. Science 2005, 308:557-560.
23. Lee Y.J., Shin J.Y., Song M.S., Lee Y.M., Choi J.G., Lee E.K., Jeong O.M., Sung H.W., Kim J.H., Kwon Y.K., Kwon J.H., Kim C.J., Webby R.J., Webster R.G., Choi Y.K. Continuing evolution of H9 influenza viruses in Korean poultry. Virology 2007, 359:313-323.
24. Leneva I.A., Roberts N., Govorkova E.A., Goloubeva O.G., Webster R.G. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. Antiviral Res. 2000, 48:101-115.
25. Leung B.W., Chen H., Brownlee G.G. Correlation between polymerase activity and pathogenicity in two duck H5N1 influenza viruses suggests that the polymerase contributes to pathogenicity. Virology 2010, 401:96-106.
26. Li Z., Xu Q., Bi D., Wang G., Cheng F. Diagnosis of avian influenza in hubei province and isolation and identification of an influenza A virus from layers. Chin. J. Prev. Vet. Med. 2001, 23:146-148.
27. Lin Y.P., Shaw M., Gregory V., Cameron K., Lim W., Klimov A., Subbarao K., Guan Y., Krauss S., Shortridge K., Webster R., Cox N., Hay A. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc. Natl Acad. Sci. USA 2000, 97:9654-9658.
28. Matskevich A.A., Moelling K. Dicer is involved in protection against influenza A virus infection. J. Gen. Virol. 2007, 88:2627-2635.
29. Matsuoka Y., Swayne D.E., Thomas C., Rameix-Welti M.A., Naffakh N., Warnes C., Altholtz M., Donis R., Subbarao K. Neuraminidase stalk length and additional glycosylation of the hemagglutinin influence the virulence of influenza H5N1 viruses for mice. J. Virol. 2009, 83:4704-4708.
30. Peiris M., Yuen K.Y., Leung C.W., Chan K.H., Ip P.L., Lai R.W., Orr W.K., Shortridge K.F. Human infection with influenza H9N2. Lancet 1999, 354:916-917.
31. Qiu M., Fang F., Chen Y., Wang H., Chen Q., Chang H., Wang F., Zhang R., Chen Z. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice. Biochem. Biophys. Res. Commun. 2006, 343:1124-1131.
32. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
33. Rehmsmeier M., Steffen P., Hochsmann M., Giegerich R. Fast and effective prediction of microRNA/target duplexes. RNA 2004, 10:1507-1517.
34. Rolling T., Koerner I., Zimmermann P., Holz K., Haller O., Staeheli P., Kochs G. Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in mice. J. Virol. 2009, 83:6673-6680.
35. Rusinov V., Baev V., Minkov I.N., Tabler M. MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence. Nucleic Acids Res. 2005, 33:W696-700.
36. Seto J.T., Rott R. Functional significance of sialidose during influenza virus multiplication. Virology 1966, 30:731-737.
37. Song M.S., Pascua P.N., Lee J.H., Baek Y.H., Lee O.J., Kim C.J., Kim H., Webby R.J., Webster R.G., Choi Y.K. The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse model. J. Virol. 2009, 83:12325-12335.
38. Sorrell E.M., Wan H., Araya Y., Song H., Perez D.R. Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc. Natl Acad. Sci. USA 2009, 106:7565-7570.
39. Suzuki Y., Ito T., Suzuki T., Holland R.E., Chambers T.M., Kiso M., Ishida H., Kawaoka Y. Sialic acid species as a determinant of the host range of influenza A viruses. J. Virol. 2000, 74:11825-11831.
40. Van Reeth K., Van Gucht S., Pensaert M. Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs. Viral Immunol. 2002, 15:583-594.
41. Wu R., Zhang H., Yang K., Liang W., Xiong Z., Liu Z., Yang X., Shao H., Zheng X., Chen M., Xu D. Multiple amino acid substitutions are involved in the adaptation of H9N2 avian influenza virus to mice. Vet. Microbiol. 2009, 138:85-91.
42. Yuan P., Bartlam M., Lou Z., Chen S., Zhou J., He X., Lv Z., Ge R., Li X., Deng T., Fodor E., Rao Z., Liu Y. Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site. Nature 2009, 909-913.
43. Zhu H., Wang J., Wang P., Song W., Zheng Z., Chen R., Guo K., Zhang T., Peiris J.S., Chen H., Guan Y. Substitution of lysine at 627 position in PB2 protein does not change virulence of the 2009 pandemic H1N1 virus in mice. Virology 2010, 401:1-5.